FI882385A - PHOSPHORUS HMG-COA REDUCTIN INHIBITOR, FOERFARANDE FOER FRAMSTAELLNING DAERAV OCH NYA MELLANPRODUKTER. - Google Patents

PHOSPHORUS HMG-COA REDUCTIN INHIBITOR, FOERFARANDE FOER FRAMSTAELLNING DAERAV OCH NYA MELLANPRODUKTER. Download PDF

Info

Publication number
FI882385A
FI882385A FI882385A FI882385A FI882385A FI 882385 A FI882385 A FI 882385A FI 882385 A FI882385 A FI 882385A FI 882385 A FI882385 A FI 882385A FI 882385 A FI882385 A FI 882385A
Authority
FI
Finland
Prior art keywords
reductin
hmg
coa
phosphorus
inhibitor
Prior art date
Application number
FI882385A
Other languages
Finnish (fi)
Other versions
FI87927C (en
FI87927B (en
FI882385A0 (en
Inventor
Donald Steven Karanewsky
Michael Christopher Badia
Scott Adams Biller
Eric Michael Gordon
Michael Joseph Sofia
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of FI882385A0 publication Critical patent/FI882385A0/en
Publication of FI882385A publication Critical patent/FI882385A/en
Application granted granted Critical
Publication of FI87927B publication Critical patent/FI87927B/en
Publication of FI87927C publication Critical patent/FI87927C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/302—Acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/303—Cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/306—Arylalkanephosphinic acids, e.g. Ar-(CH2)n-P(=X)(R)(XH), (X = O,S, Se; n>=1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3211—Esters of acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3217—Esters of acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3241—Esters of arylalkanephosphinic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI882385A 1987-05-22 1988-05-20 Process for Preparation of New Phosphorus-Containing HMG-CoA Reductase Inhibitors and New Intermediates FI87927C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5323887A 1987-05-22 1987-05-22
US5323887 1987-05-22
US10968187A 1987-10-19 1987-10-19
US10968187 1987-10-19

Publications (4)

Publication Number Publication Date
FI882385A0 FI882385A0 (en) 1988-05-20
FI882385A true FI882385A (en) 1988-11-23
FI87927B FI87927B (en) 1992-11-30
FI87927C FI87927C (en) 1993-03-10

Family

ID=26731613

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882385A FI87927C (en) 1987-05-22 1988-05-20 Process for Preparation of New Phosphorus-Containing HMG-CoA Reductase Inhibitors and New Intermediates

Country Status (24)

Country Link
JP (1) JPH01139589A (en)
KR (1) KR880013959A (en)
CN (1) CN1030761A (en)
AU (2) AU610174B2 (en)
BE (1) BE1002251A3 (en)
CH (3) CH678626A5 (en)
DE (1) DE3817298C2 (en)
DK (1) DK277388A (en)
ES (1) ES2009919A6 (en)
FI (1) FI87927C (en)
FR (1) FR2615516B1 (en)
GB (1) GB2205838B (en)
GR (1) GR880100332A (en)
HU (1) HU201085B (en)
IE (1) IE63715B1 (en)
IL (1) IL86463A (en)
IT (1) IT1217684B (en)
NL (1) NL8801331A (en)
NO (1) NO882219L (en)
NZ (1) NZ224734A (en)
PH (2) PH25581A (en)
PL (1) PL157761B1 (en)
PT (1) PT87540B (en)
SE (3) SE501541C2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86464A (en) * 1987-05-22 1993-06-10 Squibb & Sons Inc 4-phosphinyl-3- hydroxybutanoic acid derivatives useful as cholesterol biosynthesis inhibitors and pharmaceutical compositions containing the same
AU637408B2 (en) * 1989-10-10 1993-05-27 Glaxo Group Limited Substituted N-vinyl imidazole derivatives.
US5124453A (en) * 1990-03-02 1992-06-23 E. R. Squibb & Sons, Inc. Process for preparing certain 5,6,7,8-tetrahydroindolizinyl (ethyl or ethynyl)-hydroxy or methoxy-phosphinyl-3-hydroxy-butanoates and derivatives thereof
US5025000A (en) * 1990-03-02 1991-06-18 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-CoA reductase inhibitor compounds
CA2042526A1 (en) * 1990-06-11 1991-12-12 Adeoye Y. Olukotun Method for preventing a second heart attack employing an hmg coa reductase inhibitor
CA2043525A1 (en) * 1990-06-24 1991-12-25 Donald S. Karanewsky Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method
DE4023308A1 (en) * 1990-07-21 1992-01-23 Bayer Ag SUBSTITUTED PYRIDO OXAZINE
DE4025818A1 (en) * 1990-08-16 1992-02-20 Bayer Ag PHENYL SULPHONAMIDE SUBSTITUTED PYRIDINALKEN AND -AMINOOXYALKANCARBONE ACID DERIVATIVES
NZ241574A (en) * 1991-02-22 1993-08-26 Ishihara Sangyo Kaisha Substituted phenyl derivatives of hydrazone and pesticidal compositions
US5202327A (en) * 1991-07-10 1993-04-13 E. R. Squibb & Sons, Inc. Phosphorus-containing hmg-coa reductase inhibitors
US5256692A (en) * 1992-01-07 1993-10-26 E. R. Squibb & Sons, Inc. Sulfur-containing HMG-COA reductase inhibitors
US20010006644A1 (en) 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
WO2003076409A1 (en) * 2002-03-14 2003-09-18 Syngenta Participations Ag Derivatives of 1-phenyl-3-phenylpyrazole as herbicides
JP4407237B2 (en) * 2002-12-24 2010-02-03 三菱化学株式会社 Non-aqueous electrolyte and non-aqueous electrolyte secondary battery using the same
JP4485169B2 (en) 2003-05-16 2010-06-16 花王株式会社 Intestinal mineral absorption capacity improver
CN1760363B (en) * 2004-10-14 2010-04-28 蒋继宏 Coded sequence of reductase enzyme protein of eucommia 3-hydroxy-3-coenzyme of methyl glutaryl A
JP5113531B2 (en) * 2006-01-16 2013-01-09 三井化学アグロ株式会社 (3-Sulfur atom substituted phenyl) pyrazole derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR339233A (en) * 1903-12-23 1905-01-26 Cyanidgesellschaft Mit Beschra New process for obtaining explosives
DE803645C (en) * 1949-10-11 1951-04-05 Dynamit Act Ges Vormals Alfred Firedamp proof detonator in connection with electric igniters
DE918196C (en) * 1952-12-23 1954-09-20 J G W Berckholtz Fa Mass for producing colored smoke
US3274035A (en) * 1964-06-15 1966-09-20 Lohr A Burkardt Metallic composition for production of hygroscopic smoke
US3862866A (en) * 1971-08-02 1975-01-28 Specialty Products Dev Corp Gas generator composition and method
DE2841815C2 (en) * 1978-09-26 1985-02-21 Buck Chemisch-Technische Werke GmbH & Co, 7347 Bad Überkingen Method for producing a floor filling
US4438700A (en) * 1982-07-19 1984-03-27 The United States Of America As Represented By The Secretary Of The Army White smoke spotting composition for training ammunition
FR2596393B1 (en) * 1986-04-01 1988-06-03 Sanofi Sa HYDROXY-3 DIHYDROXYOXOPHOSPHORIO-4 BUTANOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
IL86464A (en) * 1987-05-22 1993-06-10 Squibb & Sons Inc 4-phosphinyl-3- hydroxybutanoic acid derivatives useful as cholesterol biosynthesis inhibitors and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
IL86463A (en) 1994-10-07
IT8820681A0 (en) 1988-05-20
SE8801904L (en) 1988-11-23
SE8801904D0 (en) 1988-05-20
FR2615516A1 (en) 1988-11-25
IL86463A0 (en) 1988-11-15
PT87540A (en) 1989-05-31
SE9201588A0 (en) 1992-05-20
CH678626A5 (en) 1991-10-15
DE3817298C2 (en) 1997-02-13
NZ224734A (en) 1991-04-26
NO882219D0 (en) 1988-05-20
SE501541C2 (en) 1995-03-06
HUT47123A (en) 1989-01-30
ES2009919A6 (en) 1989-10-16
AU643501B2 (en) 1993-11-18
PH25581A (en) 1991-08-08
KR880013959A (en) 1988-12-22
NO882219L (en) 1988-11-23
FI87927C (en) 1993-03-10
GB8811931D0 (en) 1988-06-22
FI87927B (en) 1992-11-30
FI882385A0 (en) 1988-05-20
BE1002251A3 (en) 1990-11-06
AU610174B2 (en) 1991-05-16
GB2205838A (en) 1988-12-21
AU7126691A (en) 1991-05-02
SE9201587D0 (en) 1992-05-20
HU201085B (en) 1990-09-28
GR880100332A (en) 1989-02-23
CH675582A5 (en) 1990-10-15
IT1217684B (en) 1990-03-30
DK277388A (en) 1988-11-23
FR2615516B1 (en) 1991-04-12
NL8801331A (en) 1988-12-16
GB2205838B (en) 1991-12-11
IE63715B1 (en) 1995-06-14
CN1030761A (en) 1989-02-01
CH678625A5 (en) 1991-10-15
PL157761B1 (en) 1992-06-30
SE9201587A0 (en) 1992-05-14
JPH01139589A (en) 1989-06-01
IE881544L (en) 1988-11-22
PT87540B (en) 1992-09-30
PH26578A (en) 1992-08-19
SE9201588D0 (en) 1992-05-20
DE3817298A1 (en) 1988-12-01
DK277388D0 (en) 1988-05-20
AU1650288A (en) 1988-11-24

Similar Documents

Publication Publication Date Title
FI882384A0 (en) PHOSPHORUS HMG-COA REDUCTIC INHIBITOR OCH DERAS FRAMSTAELLNINGSFOERFARANDE.
FI886006A (en) FOERFARANDE OCH ANORDNING FOER LAGRING, UTMATNING OCH PAOFOERING AV KIRURGISKA FAESTKLAEMMOR.
FI892663A0 (en) FOERFARANDE FOER STABILIZERING, SOLIDIFIERING OCH LAGRING AV AVFALL.
FI883129A (en) FOERFARANDE FOER FRAMSTAELLNING AV ORGANISERADE STRUKTURER AV KOLLAGEN, SPECIELLT AV MAENSKLIGT URSPRUNG OCH MOTSVARANDE ORGANISERADE STRUKTURER AV KOLLAGEN.
FI882827A (en) FOERFARANDE OCH ANORDNING FOR FRAMSTAELLNING AV BURKAEMNE AV STYMPAD PYRAMIDFORM.
FI882385A0 (en) PHOSPHORUS HMG-COA REDUCTIN INHIBITOR, FOERFARANDE FOER FRAMSTAELLNING DAERAV OCH NYA MELLANPRODUKTER.
FI885581A (en) ANORDNING FOER MOTTAGNING, TRANSPORTERING, FOERMINSKNING OCH FRAMMATNING AV FODERBLOCK.
FI883347A (en) NYA 5-AMINOMETHYLENE-2,4-IMIDAZOLIDINDIONER OCH 5-AMINOMETHYLENE-4-THIONOIMIDAZOLIDIN-4-ONER.
FI882993A0 (en) SILIKAPARTIKLAR, SAETT FOER FRAMSTAELLNING AV SILIKAPARTIKLAR OCH ANVAENDNING AV DESSA.
FI872147A (en) FISKFODER, FOERFARANDE FOER FRAMSTAELLNING AV DETSAMMA OCH UTFODRINGSFOERFARANDE.
FI885056A (en) NYA FLUORMETOXIFENYLDIHYDROPYRIDINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING I LAEKEMEDEL.
FI883200A (en) FOERFARANDE, ANORDNING OCH TILLBEHOER FOER MAETNING AV VAEVNADSPLASMINOGENAKTIVATOR-AKTIVITET.
FI885722A0 (en) NYA KINOLINDERIVAT, FOERFARANDEN FOER FRAMSTAELLNING DAERAV OCH ANTIBAKTERIELLA AEMNEN INNEHAOLLANDE DESAMMA.
FI884225A0 (en) NYA AMINOSYRAESTRAR, FOERFARANDEN FOER DERAS FRAMSTAELLNING, DESSA INNEHAOLLANDE LAEKEMEDEL OCH DERAS ANVAENDNING.
FI882475A (en) FRAMSTAELLNINGSFOERFARANDE AV NYA 5- (-AMMONIOACYLOXIMETYLEN) TETRAHYDROFURANER OCH TETRAHYDROTIOFENER.
FI884890A0 (en) NYA ISOPOLYPEPTIDER OCH FOERFARANDE FOER FRAMSTAELLNING DAERAV.
FI901548A0 (en) NYA A-GLUCOSIDASIN INHIBITOR.
FI882180A (en) NYA ALKYLERADE VAEXTHORMONER FRIGOERANDE PEPTIDER OCH FOERFARANDE FOER BEHANDLING AV DAEGGDJUR MEDELST HJAELP AV DESSA.
FI875327A (en) FOERFARANDE OCH ANORDNING FOER FRAMSTAELLNING AV BETONGSTOMELEMENT, ISYNNERHET BJAELKAR.
FI881906A (en) SAETT OCH ANORDNING FOR RENOVERING AV EN FRAON EN VAEGG UTSKJUTANDE, ARMERAD BETONGPLATTA.
FI885057A (en) NYA FLUORMETOXIFENYLDIHYDROPYRIDINER, FOERFARANDEN FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING I LAEKEMEDEL.
FI875168A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA RODIUMHYDRERINGSKATALYSATORER OCH ANVAENDNING AV DESSA.
FI873317A0 (en) FOERFARANDE OCH ANORDNING FOER BESTRYKNING AV LAONGSTRAECKTA STAOLSTYCKEN, ISYNNERHET BETONGSTAOL OCH STAOLPROFILER.
FI871034A0 (en) FOERFARANDE OCH ANORDNING FOER STAPLING AV BALAR.
FI881471A (en) NYA ALKANSYRAALKYLESTRAR, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH ANVAENDNING AV VATTENHALTIGA EMULSIONER AV DESSA I VACCINER.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: E.R. SQUIBB & SONS, INC.

MA Patent expired